OBJECTIVE: Ga-DOTATATE PET/CT as an appropriate test in the management of NETs. CONCLUSION: Ga-DOTATATE PET/CT can noninvasively assess tumor heterogeneity, especially in G2 and G3 NETs, for personalized management of patients.
No takes yet. Share an insight, caveat, or question.
Şanlı et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: